[Late results of the D-penicillamine treatment of rheumatoid arthritis]. 1981

E R Agababova, and S M Sidel'nikova, and E M Aseeva, and N V Nikol'skaia, and R A Gaziian

UI MeSH Term Description Entries
D010396 Penicillamine 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease. Dimethylcysteine,Mercaptovaline,beta,beta-Dimethylcysteine,Copper Penicillaminate,Cuprenil,Cuprimine,D-3-Mercaptovaline,D-Penicillamine,Metalcaptase,D 3 Mercaptovaline,D Penicillamine,Penicillaminate, Copper,beta,beta Dimethylcysteine
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

E R Agababova, and S M Sidel'nikova, and E M Aseeva, and N V Nikol'skaia, and R A Gaziian
January 1978, Voprosy revmatizma,
E R Agababova, and S M Sidel'nikova, and E M Aseeva, and N V Nikol'skaia, and R A Gaziian
January 1975, Reumatizam,
E R Agababova, and S M Sidel'nikova, and E M Aseeva, and N V Nikol'skaia, and R A Gaziian
August 1986, Ryumachi. [Rheumatism],
E R Agababova, and S M Sidel'nikova, and E M Aseeva, and N V Nikol'skaia, and R A Gaziian
January 1978, Medicinski arhiv,
E R Agababova, and S M Sidel'nikova, and E M Aseeva, and N V Nikol'skaia, and R A Gaziian
December 1978, The Nebraska medical journal,
E R Agababova, and S M Sidel'nikova, and E M Aseeva, and N V Nikol'skaia, and R A Gaziian
June 1974, Der Internist,
E R Agababova, and S M Sidel'nikova, and E M Aseeva, and N V Nikol'skaia, and R A Gaziian
November 1971, Arzneimittel-Forschung,
E R Agababova, and S M Sidel'nikova, and E M Aseeva, and N V Nikol'skaia, and R A Gaziian
January 1975, Journal belge de rhumatologie et de medecine physique = Belgisch tijdschrift voor reumatologie en fysische geneeskunde,
E R Agababova, and S M Sidel'nikova, and E M Aseeva, and N V Nikol'skaia, and R A Gaziian
January 1972, Reumatologia,
E R Agababova, and S M Sidel'nikova, and E M Aseeva, and N V Nikol'skaia, and R A Gaziian
January 1977, Reumatismo,
Copied contents to your clipboard!